What are Infusion Therapies for Parkinson's Disease?

Infusion therapies are treatments that deliver medication directly into the bloodstream through an intravenous (IV) line or pump. In Parkinson’s disease, infusion therapies are often used for patients who have difficulty managing their symptoms with oral medications, particularly in the later stages of the disease. These therapies help to improve motor symptoms, such as tremors, stiffness, and bradykinesia (slowness of movement), and can provide more consistent and stable symptom control compared to oral medications.

Types of Infusion Therapies for Parkinson’s Disease
1. Levodopa-Carbidopa Intestinal Gel (Duodopa®)

What It Is: Levodopa-carbidopa intestinal gel delivers levodopa directly into the small intestine through a tube placed in the stomach. It provides a steady dose of medication, helping reduce “on-off” fluctuations experienced with oral levodopa.

How It Works:
  • The gel is infused directly into the duodenum using a pump.
  • Provides a steady supply of levodopa, improving symptoms and motor function.
  • Reduces sudden “off” periods and improves consistency of symptom control.
Who Can Benefit:
  • Patients with motor fluctuations despite oral medications.
  • Those who have difficulty swallowing pills or absorbing medications.
Considerations:
  • Requires surgical placement of a tube in the stomach (PEG).
  • Needs ongoing monitoring and adjustments by a healthcare provider.
  • Delivered over 16–24 hours via a pump.
2. Apomorphine

What It Is: Apomorphine acts quickly to provide relief from Parkinson's symptoms during "off" periods. It can be given as an injection or through an infusion pump.

How It Works:
  • Stimulates dopamine receptors in the brain to improve rigidity, tremors, and bradykinesia.
  • Provides quick and steady symptom control when oral medications are insufficient.
Who Can Benefit:
  • Patients with unpredictable "off" periods.
  • Those needing quick relief from severe motor symptoms.
Considerations:
  • Side effects can include nausea, low blood pressure, and hallucinations.
  • Usually given via subcutaneous injection or infusion with a small device under the skin.
  • Infusion may be intermittent or continuous.
3. Continuous Intravenous (IV) Dopamine Agonists

What It Is: Continuous IV infusion of dopamine agonists (e.g., rotigotine, pramipexole) may be used when other treatments are not effective.

How It Works:
  • Mimics dopamine in the brain to control motor symptoms.
  • Delivered via IV pump continuously or at intervals to maintain stable dopamine levels.
Who Can Benefit:
  • Patients with motor fluctuations or poor response to oral medications.
  • Those unable to use other delivery methods.
Considerations:
  • Requires hospitalization or home care monitoring.
  • Possible side effects include low blood pressure, drowsiness, and gastrointestinal issues.
Benefits of Infusion Therapies
  • Improved Symptom Control: Provides consistent symptom relief and reduces "on-off" fluctuations.
  • Better Absorption: Direct delivery into the bloodstream bypasses gastrointestinal absorption issues.
  • Reduced "On-Off" Fluctuations: Smooths out peaks and valleys of Parkinson's symptoms for better daily control.
Risks and Considerations
  • Surgical Insertion: Some therapies, like Duodopa®, require surgery to place a tube.
  • Side Effects: Can include nausea, dizziness, or confusion. Medication adjustments may be necessary.
  • Care and Maintenance: Requires training to manage pumps and therapy effectively at home or in clinical settings. Some therapies may not be available in India.
Who is a Candidate for Infusion Therapy?
  • Significant motor fluctuations not controlled by oral medications.
  • Difficulty swallowing pills or gastrointestinal absorption issues.
  • Trouble managing symptoms even with high-dose oral medications.
Conclusion

Infusion therapies can provide effective symptom relief for individuals with advanced Parkinson’s disease who struggle with controlling their motor symptoms. Therapies like Duodopa®, Apomorphine, and continuous IV dopamine agonists deliver medication directly into the bloodstream, offering more consistent symptom control. While not suitable for everyone, these therapies can significantly improve quality of life for patients unresponsive to oral medications.